The Labor and Delivery Unit at Hutchinson Regional Medical Center (HRMC) is the first in Kansas to use the new Jada Hemorrhage Management System, a vacuum-induced hemorrhage control device for treating abnormal postpartum uterine bleeding and postpartum hemorrhage. The Food and Drug Administration (FDA) approved the Jada System in August 2020 and the early-adopting hospitals are reporting favorable outcomes.
Jill White, Director of Patient Care at Hutchinson Regional Medical Center, said abnormal postpartum bleeding may occur after birth and can quickly become an obstetric emergency. “With postpartum hemorrhage being the leading cause of maternal mortality, accounting for 25 percent of maternal deaths due to obstetric complications, there is a critical need for effective and easy treatment options,” White said. “Data exists that the Jada System provides rapid, effective control of abnormal postpartum uterine bleeding. Hutchinson Regional started utilizing the device in February.” 
The Jada System is comprised of a soft silicone loop which connects to a vacuum source. The loop is inserted into the uterus and has vacuum pores inside a protective shield. An expandable Cervical Seal is filled with sterile fluid to create a seal that holds a vacuum within the uterus. With the Jada System attached to the vacuum source, a gentle suction is created to evacuate blood and help the uterine muscles tighten.
Ken Johnson, President and CEO of Hutchinson Regional Healthcare System, said the FDA stamp of approval powerfully confirms the worthiness of medical instruments like the Jada device. “Hutchinson Regional enjoys a reputation as being on the leading edge of deploying FDA-approved mechanisms, and the Jada System is another example of doing so,” Johnson said. “This may be a life saving device.”
Hutchinson Regional Medical Center is an entity of Hutchinson Regional Healthcare System. Other entities are Horizons Mental Health Center, Hospice & HomeCare of Reno County, Health-E-Quip and Hutchinson Regional Medical Foundation.
